PubRank

Michael J Shattock

Author PubWeight™ 43.93‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Serine 68 phosphorylation of phospholemman: acute isoform-specific activation of cardiac Na/K ATPase. Cardiovasc Res 2005 2.16
2 Experimental hyperleptinemia in neonatal rats leads to selective leptin responsiveness, hypertension, and altered myocardial function. Hypertension 2013 2.06
3 Characterization of the phospholemman knockout mouse heart: depressed left ventricular function with increased Na-K-ATPase activity. Am J Physiol Heart Circ Physiol 2007 1.77
4 Mitochondrial uncoupling, with low concentration FCCP, induces ROS-dependent cardioprotection independent of KATP channel activation. Cardiovasc Res 2006 1.56
5 Ischemia-induced phosphorylation of phospholemman directly activates rat cardiac Na/K-ATPase. FASEB J 2003 1.45
6 Differential distribution and regulation of mouse cardiac Na+/K+-ATPase alpha1 and alpha2 subunits in T-tubule and surface sarcolemmal membranes. Cardiovasc Res 2006 1.28
7 Mouse isolated perfused heart: characteristics and cautions. Clin Exp Pharmacol Physiol 2003 1.26
8 Detection, quantitation, purification, and identification of cardiac proteins S-thiolated during ischemia and reperfusion. J Biol Chem 2002 1.25
9 FXYD1 phosphorylation in vitro and in adult rat cardiac myocytes: threonine 69 is a novel substrate for protein kinase C. Am J Physiol Cell Physiol 2009 1.20
10 Cardiac ischemia causes inhibition of the Na/K ATPase by a labile cytosolic compound whose production is linked to oxidant stress. Cardiovasc Res 2003 1.11
11 FCCP is cardioprotective at concentrations that cause mitochondrial oxidation without detectable depolarisation. Cardiovasc Res 2006 1.05
12 Pivotal role of NOX-2-containing NADPH oxidase in early ischemic preconditioning. FASEB J 2005 1.02
13 The intracellular region of FXYD1 is sufficient to regulate cardiac Na/K ATPase. FASEB J 2007 1.02
14 The rate of loss of T-tubules in cultured adult ventricular myocytes is species dependent. Exp Physiol 2010 1.00
15 Cardioprotection initiated by reactive oxygen species is dependent on activation of PKCepsilon. Am J Physiol Heart Circ Physiol 2006 0.97
16 Glyceraldehyde phosphate dehydrogenase oxidation during cardiac ischemia and reperfusion. J Mol Cell Cardiol 2002 0.93
17 Is there a transient rise in sub-sarcolemmal Na and activation of Na/K pump current following activation of I(Na) in ventricular myocardium? Cardiovasc Res 2003 0.92
18 The inhibitory effect of phospholemman on the sodium pump requires its palmitoylation. J Biol Chem 2011 0.92
19 Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit vascular smooth muscle cell proliferation via differential effects on the cell cycle. J Pharm Pharmacol 2003 0.92
20 Reversible cysteine-targeted oxidation of proteins during renal oxidative stress. J Am Soc Nephrol 2003 0.91
21 A separate pool of cardiac phospholemman that does not regulate or associate with the sodium pump: multimers of phospholemman in ventricular muscle. J Biol Chem 2013 0.91
22 Phospholemman-dependent regulation of the cardiac Na/K-ATPase activity is modulated by inhibitor-1 sensitive type-1 phosphatase. FASEB J 2011 0.90
23 Phospholemman Ser69 phosphorylation contributes to sildenafil-induced cardioprotection against reperfusion injury. Am J Physiol Heart Circ Physiol 2010 0.88
24 Reperfusion kinase phosphorylation is essential but not sufficient in the mediation of pharmacological preconditioning: Characterisation in the bi-phasic profile of early and late protection. Cardiovasc Res 2006 0.88
25 Novel regulation of cardiac Na pump via phospholemman. J Mol Cell Cardiol 2013 0.87
26 The role of the Na+/Ca2+ exchanger, I(Na) and I(CaL) in the genesis of dofetilide-induced torsades de pointes in isolated, AV-blocked rabbit hearts. Br J Pharmacol 2009 0.86
27 Antimycin A induced cardioprotection is dependent on pre-ischemic p38-MAPK activation but independent of MKK3. J Mol Cell Cardiol 2005 0.85
28 Nitric oxide regulates cardiac intracellular Na⁺ and Ca²⁺ by modulating Na/K ATPase via PKCε and phospholemman-dependent mechanism. J Mol Cell Cardiol 2013 0.83
29 Esmolol cardioplegia: the cellular mechanism of diastolic arrest. Cardiovasc Res 2010 0.83
30 Cell volume control in phospholemman (PLM) knockout mice: do cardiac myocytes demonstrate a regulatory volume decrease and is this influenced by deletion of PLM? Exp Physiol 2008 0.82
31 S-thiolation of HSP27 regulates its multimeric aggregate size independently of phosphorylation. J Biol Chem 2002 0.82
32 Maternal dietary supplementation with saturated, but not monounsaturated or polyunsaturated fatty acids, leads to tissue-specific inhibition of offspring Na+,K+-ATPase. J Physiol 2008 0.81
33 Regulation of the cardiac Na(+) pump by palmitoylation of its catalytic and regulatory subunits. Biochem Soc Trans 2013 0.81
34 Responses to ischaemia and reperfusion in the mouse isolated perfused heart and the phenomenon of 'contractile cycling'. Clin Exp Pharmacol Physiol 2003 0.81
35 Increased cardiovascular reactivity to acute stress and salt-loading in adult male offspring of fat fed non-obese rats. PLoS One 2011 0.80
36 Role of p38-mitogen-activated protein kinase in ischaemic preconditioning in rat heart. Clin Exp Pharmacol Physiol 2007 0.80
37 Inhibition of human mesangial cell proliferation by targeting T-type calcium channels. Nephron Exp Nephrol 2009 0.80
38 Phospholemman and the cardiac sodium pump: protein kinase C, take a bow. Circ Res 2006 0.79
39 Purification of proteins susceptible to oxidation at cysteine residues: identification of malate dehydrogenase as a target for S-glutathiolation. Ann N Y Acad Sci 2002 0.79
40 Ischemic preconditioning: a potential role for protein S-thiolation? Antioxid Redox Signal 2005 0.79
41 Influence of isoprostane F2alpha-III on reflow after myocardial infarction. Eur Heart J 2004 0.78
42 Anti-proliferative actions of T-type calcium channel inhibition in Thy1 nephritis. Am J Pathol 2013 0.77
43 Evidence for a novel K(+) channel modulated by alpha(1A)-adrenoceptors in cardiac myocytes. Mol Pharmacol 2004 0.76
44 Response to role of hyperleptinemia in the regulation of blood pressure and cardiac function. Hypertension 2014 0.75
45 The salt of the earth: focus on Na⁺ regulation in the cardiac myocyte. J Mol Cell Cardiol 2013 0.75